Masafumi Seki

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Pulmonary Hypertension

Respiratory Syncytial Virus

Top Venues

Infection and drug resistance

International journal of general medicine

International medical case reports journal

This page only lists publications with an associated author ORCID identifier.

Publications

Masafumi Seki
Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan. International journal of general medicine 17 (2024)
Daishi Shimada, Masafumi Seki
Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses. Infection and drug resistance 17 (2024)
Daishi Shimada, Masafumi Seki
Severe Respiratory Syncytial Virus Infections in Elderly Persons During the COVID-19 Pandemic. Infection and drug resistance 17 (2024)
Masafumi Seki
Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan. International journal of general medicine 17 (2024)
Daishi Shimada, Masafumi Seki
Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses. Infection and drug resistance 17 (2024)
Daishi Shimada, Masafumi Seki
Severe Respiratory Syncytial Virus Infections in Elderly Persons During the COVID-19 Pandemic. Infection and drug resistance 17 (2024)
Takuma Soga, Calvin Duong, David J Pattinson, Yuko Sakai-Tagawa, Akifumi Tokita, Naomi Izumida, Tamon Nishino, Haruhisa Hagiwara, Noriyuki Wada, Yumi Miyamoto, Haruo Kuroki, Yuka Hayashi, Masafumi Seki, Natsuko Kasuya, Michiko Koga, Eisuke Adachi, Kiyoko Iwatsuki-Horimoto, Hiroshi Yotsuyanagi, Seiya Yamayoshi, Yoshihiro Kawaoka
Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in Japan. Viruses 15 (2) (2023)
Masafumi Seki, Haruka Karaushi, Noriko Arai, Takeshi Hayashi, Kotaro Mitsutake
COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem. Infection and drug resistance 16 (2023)
Daishi Shimada, Motoyasu Sagawa, Masafumi Seki
Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease. Infection and drug resistance 16 (2023)
Daishi Shimada, Motoyasu Sagawa, Masafumi Seki
Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease. Infection and drug resistance 16 (2023)
Takuma Soga, Calvin Duong, David J Pattinson, Yuko Sakai-Tagawa, Akifumi Tokita, Naomi Izumida, Tamon Nishino, Haruhisa Hagiwara, Noriyuki Wada, Yumi Miyamoto, Haruo Kuroki, Yuka Hayashi, Masafumi Seki, Natsuko Kasuya, Michiko Koga, Eisuke Adachi, Kiyoko Iwatsuki-Horimoto, Hiroshi Yotsuyanagi, Seiya Yamayoshi, Yoshihiro Kawaoka
Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in Japan. Viruses 15 (2) (2023)
Yuji Watanabe, Hirohito Sano, Shuichi Konno, Yasuhiro Kamioka, Maya Hariu, Kazuki Takano, Mitsuhiro Yamada, Masafumi Seki
Sinobronchial Syndrome Patients with Suspected Non-Tuberculous Mycobacterium Infection Exacerbated by Exophiala dermatitidis Infection. Infection and drug resistance 15 (2022)
Masafumi Seki, Kosuke Hashimoto, Nami Kondo, Yoshitaka Ohya, Futoshi Kotajima, Kotaro Mitsutake
Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy. Infection and drug resistance 15 (2022)
Daisuke Fukushi, Keigo Murakami, Yuji Watanabe, Norihiko Sugimoto, Hirotsugu Uehara, Masafumi Seki
Pulmonary and Disseminated Mycobacterium avium Complex Cases Confirmed by Tissue-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay of Formalin-Fixed Paraffin-Embedded Tissues. Infection and drug resistance 15 (2022)
Masafumi Seki, Kosuke Hashimoto, Nami Kondo, Yoshitaka Ohya, Futoshi Kotajima, Kotaro Mitsutake
Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy. Infection and drug resistance 15 (2022)
Yuji Watanabe, Yasuhiro Kamioka, Masafumi Seki
Rhinovirus-Infected Patients in the COVID-19 Pandemic Period. Infection and drug resistance 14 (2021)
Kazuki Takano, Daishi Shimada, Shota Kashiwagura, Yasuhiro Kamioka, Maya Hariu, Yuji Watanabe, Masafumi Seki
Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan. International medical case reports journal 14 (2021)
Haruka Imai, Yuji Watanabe, Daishi Shimada, Jun Suzuki, Shiro Endo, Mitsuo Kaku, Masafumi Seki
Utility of a Cell-Direct Polymerase Chain Reaction-Based Nucleic Acid Lateral Flow Immunoassay for Detection of Bacteria in Peripheral Blood Leukocytes of Suspected Sepsis Cases. Infection and drug resistance 14 (2021)
Kazuki Takano, Yuji Watanabe, Maya Hariu, Masafumi Seki
Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan. Infection and drug resistance 14 (2021)
Shota Kashiwagura, Yasuhiro Kamioka, Masafumi Seki, Satoshi Koshika, Kouji Okada
Analysis of Risk Factors Associated with Reduced Trough Concentrations of Vancomycin in Relation to Renal Function in a Tertiary Hospital in Japan. Infection and drug resistance 14 (2021)
Masafumi Seki
Strategies for Geriatric Pneumonia in Healthcare Facilities - How Effective is Combined Influenza and Pneumococcal Vaccination? International journal of general medicine 13 (2020)
Yasuhiro Kamioka, Shota Kashiwagura, Masafumi Seki
Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan. Clinical pharmacology : advances and applications 12 (2020)